Call For Abstracts


Click here to login and view your submitted abstracts.

Notification of acceptance will be sent to the submitted author by August 5, 2015.


Cell Transplant:

  • Adult Stem Cells
  • Animals Models
  • Bioengineering and Biomaterials
  • Bone Marrow and Hematopoietic
  • Cardiac Cells
  • Cartilage and Bone
  • Cell Banking and Preservation
  • Clinical Islet Transplantation
  • Embryonic Stem Cells
  • Encapsulation
  • Ethics in Cellular Therapies and Xenotransplantation
  • Gene Therapy
  • Immunobiology
  • Immunology
  • Immunosuppression
  • Islet Cells
  • Liver Cells
  • Muscle Cells
  • Neural Cells
  • Organ and Tissue Procurement
  • Tissue and Cell Culture/Expansion Platform Technologies
  • Tissue Engineering
  • Transdifferentiation, Tissue Reprogramming and Regeneration
  • Tolerance
  • Xenoantigens and antibodies
  • Xenotransplantation
  • Metabolism and Nutrition

Islet and Pancreas:

  • Clinical pancreas transplantation
  • Experimental Islet transplantation
  • Technical aspects: islet isolation and culture
  • Clinical allo islet transplantation
  • Clinical auto islet transplantation
  • Immunoisolation, encapsulation, extrahepatic sites
  • Xenotransplantation
  • Islet cell biology
  • Engraftment and graft monitoring
  • Immunology, tolerance
  • Beta cell survival and injury mechanisms
  • Technical aspects: procurement and preservation
  • Assessment of the islet graft and graft imaging
  • Stem cells and beta cell regeneration
  • Experimental pancreas transplantation
  • Organ and Tissue engineering and regeneration
  • Immunosuppression for islet and pancreas transplantation


  • Cell and Tissue Xenotransplantation (Non-Islet)
  • Ethics, Regulation and Public Perception
  • Genetic Engineering of the Donor
  • Infectious Risk
  • Inflammation and Coagulation – Small Animal and In Vitro Models
  • Innate Immune Cells
  • Non-Gal Antibodies and Antigens
  • Not Specified
  • Preclinical and Clinical Islet Xenotransplantation
  • Preclinical Solid Organ Xenotransplantation
  • Tolerogenic Strategies
  • Xenotransplantation Methodology and Resources



  • Abstracts must be submitted in English.
  • Notification of acceptance will be sent to submitted author by August 5, 2015. Scheduling details and instructions for presentations will be included with this correspondence.
  • Submissions not conforming to established guidelines will not be reviewed.


  • Abstracts should be concise and informative.
  • Abstracts stating merely that the results will be presented or discussed are considered uninformative and will be subject to rejection.


  • All abstracts must be submitted through the online form.
  • Please be sure your abstract is in final form. It will appear in the Final Program as you have submitted it.
  • Conflict of Interest and Disclosure Statement: All authors must disclose conflicts of interest. The electronic submission process will not allow abstracts to be submitted without this information being completed for each author.


  • Oral Abstract Presentation: Abstract accepted for Oral Abstract Session will have 8 minutes presentation, followed by 2 minutes question time.
  • Poster Presentation
  • Either

NOTE: Submissions for “oral presentations” or “either” may be accepted as submitted or converted by the reviewing committee into a poster, a mini-oral presentation, or a video poster presentation. Submissions for either may be considered for the same formats.


  • Size: The maximum length for an abstract is 3000 characters, excluding spaces. Titles, authors, study groups, acknowledgements, references and images are not counted in this maximum.
  • Title: Abstract title must be in sentence case. DO NOT type in uppercase. Only cap the first word and proper nouns. Do not indent. Title should be concise and indicate the content of the abstract.
  • Authors: Take care to list the authors in the relevant section of the submission site. Spell out completely the names of all authors using full first and last names. Maintain consistency in author names on multiple abstracts to avoid duplication in the Author Index. Enter all the institutions of all the authors (i.e. Department of Surgery, Faculty of Medicine, University of Miami, Miami, FL, USA)
  • Presenting Author: In all printed publications the presenting author will be underlined. Please note: Because of production deadlines, as of September 15, 2015, any changes to the presenting author will not be reflected in the Final Program. A maximum of 3 orals per person are permitted, but no limit on submission.
  • Body of Abstract: The abstract should be informative and detailed.
  • It is NOT acceptable to state that "The results will be discussed." Inclusion of specific data is necessary for reviewers.
  • Indicate the major new findings of the study.
  • Standard abbreviations may be used as follows: on first use, spell out the full term and follow with abbreviation in parentheses.
  • The use of tables, graphs and other types of images in abstracts is discouraged. Should you need to add tables and figures, you must reference them in the body of your abstract and upload a maximum of two images, figures or graphs under the abstract body box.
  • Topic List: Authors must select an abstract topic (only one) from the provided list.
  • The use of trade names, company identifications or product names is discouraged.

Click here to login and view your submitted abstracts.

TSS 2015 Logo